KNSA logo

Kiniksa Pharmaceuticals (KNSA) Long Term Debt

Annual Long Term Debt

$10.01 M
+$7.39 M+282.16%

December 31, 2023


Summary


Performance

KNSA Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKNSAbalance sheetmetrics:

Quarterly Long Term Debt

$8.56 M
-$753.00 K-8.08%

September 30, 2024


Summary


Performance

KNSA Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKNSAbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

KNSA Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+282.2%-19.6%
3 y3 years+105.1%+144.8%
5 y5 years+100.0%+515.7%

KNSA Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+282.2%-24.1%+570.1%
5 y5-yearat high+947.6%-24.1%>+9999.0%
alltimeall timeat high-100.0%-24.1%-100.0%

Kiniksa Pharmaceuticals Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$8.56 M(-8.1%)
Jun 2024
-
$9.32 M(-5.5%)
Mar 2024
-
$9.86 M(-1.4%)
Dec 2023
$10.01 M(+282.2%)
$10.01 M(-6.1%)
Sep 2023
-
$10.65 M(-5.6%)
Jun 2023
-
$11.28 M(+429.0%)
Mar 2023
-
$2.13 M(-18.5%)
Dec 2022
$2.62 M(-1.9%)
$2.62 M(-23.8%)
Sep 2022
-
$3.44 M(+168.8%)
Jun 2022
-
$1.28 M(-39.0%)
Mar 2022
-
$2.10 M(-21.5%)
Dec 2021
$2.67 M
$2.67 M(-23.7%)
DateAnnualQuarterly
Sep 2021
-
$3.50 M(-0.0%)
Jun 2021
-
$3.50 M(-16.7%)
Mar 2021
-
$4.20 M(-13.9%)
Dec 2020
$4.88 M(+410.8%)
$4.88 M(+8769.1%)
Sep 2020
-
$55.00 K(-60.4%)
Jun 2020
-
$139.00 K(-74.8%)
Mar 2020
-
$551.00 K(-42.3%)
Dec 2019
$955.00 K(>+9900.0%)
$955.00 K(-31.3%)
Sep 2019
-
$1.39 M(-23.5%)
Jun 2019
-
$1.82 M(-18.8%)
Mar 2019
-
$2.24 M(>+9900.0%)
Dec 2018
$0.00
$0.00

FAQ

  • What is Kiniksa Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual long term debt year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly long term debt year-on-year change?

What is Kiniksa Pharmaceuticals annual long term debt?

The current annual long term debt of KNSA is $10.01 M

What is the all time high annual long term debt for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual long term debt is $10.01 M

What is Kiniksa Pharmaceuticals annual long term debt year-on-year change?

Over the past year, KNSA annual long term debt has changed by +$7.39 M (+282.16%)

What is Kiniksa Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of KNSA is $8.56 M

What is the all time high quarterly long term debt for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly long term debt is $11.28 M

What is Kiniksa Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, KNSA quarterly long term debt has changed by -$2.09 M (-19.59%)